Susquehanna analyst issues NEUTRAL recommendation for INFY on January 15, 2026 02:12PM ET. The previous analyst recommendation was Neutral.INFY was trading at $18.63 at issue of the analyst recommendation.The overall...
Needham analyst issues BUY recommendation for TSM on January 15, 2026 01:49PM ET. The previous analyst recommendation was Buy.TSM was trading at $327.11 at issue of the analyst recommendation.The overall...
BMO Capital analyst issues MARKET PERFORM recommendation for INFY on January 15, 2026 12:20PM ET. The previous analyst recommendation was Market Perform.INFY was trading at $19.35 at issue of the...
Wells Fargo analyst issues OVERWEIGHT recommendation for ASML on January 15, 2026 11:33AM ET. The previous analyst recommendation was Overweight.ASML was trading at $1263.72 at issue of the analyst recommendation.The...
KGI Securities analyst issues OUTPERFORM recommendation for ASML on January 15, 2026 09:59AM ET. ASML was trading at $1263.72 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current...
Morgan Stanley analyst issues OVERWEIGHT recommendation for NOK on January 15, 2026 09:28AM ET. The previous analyst recommendation was Equal-Weight.NOK was trading at $6.36 at issue of the analyst recommendation.The...
Citigroup analyst issues NEUTRAL recommendation for PAC on January 14, 2026 11:53PM ET. The previous analyst recommendation was Buy.PAC was trading at $263.2 at issue of the analyst recommendation.The overall...
Goldman Sachs analyst issues NEUTRAL recommendation for INFY on January 14, 2026 08:21PM ET. The previous analyst recommendation was Neutral.INFY was trading at $19.35 at issue of the analyst recommendation.The...
RBC Capital analyst issues OUTPERFORM recommendation for ASML on January 14, 2026 09:25PM ET. ASML was trading at $1263.72 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current...
Morgan Stanley analyst issues UNDERWEIGHT recommendation for GSK on January 14, 2026 04:49PM ET. The previous analyst recommendation was Underweight.GSK was trading at $50.625 at issue of the analyst recommendation.The...
